Eradicating residual chronic myeloid leukaemia: basic research lost in translation

Lancet Haematol. 2021 Feb;8(2):e101-e104. doi: 10.1016/S2352-3026(21)00001-6.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Chronic Disease / mortality
  • Chronic Disease / therapy*
  • Disease Progression
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Neoplastic Stem Cells / drug effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors

Associated data

  • ClinicalTrials.gov/NCT03654768